Tag - Immunotherapy

Abbott to acquire Exact Sciences

Leading Diagnostics Companies Join Forces to Establish the Access to Comprehensive Genomic Profiling Coalition (ACGP)

Syapse Announces $30M Financing to Advance the Use of Real-World Evidence

2019 in Review – Major Acquisitions, Population Studies, Gigantic Founding Rounds, Technological Advancements, and ….

An interview with Michael Snyder, Stanford W. Ascherman Professor and Chair, Department of Genetics & Director, Center for Genomics and Personalized Medicine

Mike Pellini, Section 32: “I hope we will find a way where the payers and the healthcare industry will work much more closely together to generate the data that will ultimately be useful in answering difficult, cost-based decisions.”

Immunotherapy and the Basis of Neoantigen Biology: Part II Cancer Immunotherapies

Immunotherapy and the Basis of Neoantigen Biology: Part I Neoantigens

2018: Population Studies, Immunotherapy, CRISPR, Genomic Medicine,…2019

PMWC 2017 Silicon Valley: Data sharing, privacy, and security

Can 2017 top 2016?

The JP Morgan Healthcare Conference from Afar

Copyright © 2026. enlighenbio LLC. All rights reserved.